undamentalytics Newsletter

Cryo Cell International Inc balance sheet

At the end of fiscal 2025, Cryo Cell International Inc had total assets of $61.7m, total liabilities of $80.3m and shareholders' equity of −$18.6m. It held $319,031 in cash against $10.7m of debt: net debt of $10.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cryo Cell International Inc: balance sheet, annual
Fiscal year2010Nov 20102011Nov 20112012Nov 20122013Nov 20132014Nov 20142015Nov 20152016Nov 20162017Nov 20172018Nov 20182019Nov 20192020Nov 20202021Nov 20212022Nov 20222023Nov 20232024Nov 20242025Nov 2025LTMAug 2026
Cash and equivalents863434366710820101
Receivables23334345666567777
Inventory————0000111111101
Total current assets13149981091315151916109131213
Goodwill————0200222222222
Total assets1819121210192024434346616565656262
Accounts payable11111112111123232
Deferred revenue (current)5677777789991010101010
Total current liabilities81111109101314151516211921222015
Long-term debt43222211196299888
Total debt432222129161294111012118
Total liabilities—————243536515049566672788079
Shareholders' equity−1−2−9−9−11−5−15−13−9−7−34−2−11−13−19−16
Non-controlling interests and other (assets − liabilities − equity)—————————————3———
Net debt (negative = net cash)−5−3−0−2−1−283106−1−49911107
Shares outstanding12m12m11m11m10m9m7m7m8m8m8m9m9m8m8m8m8m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: AMS vs CCELCCEL vs HAOAHG vs CCEL

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Cryo Cell International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cryo Cell International Inc.